Blueprint Medicines Corp Business Operations Contracts & Agreements

15 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Consent and Termination Agreement, dated February 22, 2024, by and between the Registrant and Royalty Pharma Investments 2019 ICAV
Termination Agreements
Blueprint Medicines Corp
Biotechnology
NY
2024
Amendment No. 2 to Collaboration and License Agreement, dated as of July 27, 2023, between Blueprint Medicines Corporation and Oncopia Therapeutics, Inc. d/b/a Proteovant...
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2023
Amendment No. 1 to Collaboration and License Agreement, dated as of June 5, 2023, between Blueprint Medicines Corporation and Oncopia Therapeutics, Inc. d/b/a Proteovant...
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2023
Mutual Termination Agreement, effective as of April 30, 2023, by and between F. Hoffman La Roche Ltd, Hoffman-La Roche Inc. and the Registrant
Termination Agreements
Blueprint Medicines Corp
Biotechnology
2023
Tenth Amendment to Collaboration and License Agreement, effective August 4, 2016, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and the Registrant
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2022
Collaboration and License Agreement dated as of February 26, 2022 by and between Oncopia Therapeutics, Inc., d/b/a Proteovant Therapeutics, Inc. and the Registrant
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
NY
2022
Sales Agreement, dated as of February 17, 2022, by and between Blueprint Medicines Corporation and Cowen and Company, LLC
Sales Agreements
Blueprint Medicines Corp
Biotechnology
NY
2022
Ninth Amendment to Collaboration and License Agreement, effective January 8, 2021, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and the Registrant
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2021
Sales Agreement, dated as of July 30, 2020, by and between Blueprint Medicines Corporation and Cowen and Company, LLC
Sales Agreements
Blueprint Medicines Corp
Biotechnology
NY
2020
Eighth Amendment to Collaboration and License Agreement, effective April 30, 2020, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines Corporation
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2020
Seventh Amendment to Collaboration and License Agreement, effective December 17, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines...
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2019
Sixth Amendment to Collaboration and License Agreement, effective November 1, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines...
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2019
Fifth Amendment to Collaboration and License Agreement, effective June 28, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and Blueprint Medicines Corporation
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2019
Fourth Amendment to Collaboration and License Agreement, effective February 25, 2019, by and among F. Hoffmann-La Roche Ltd, Hoffmann-La Roche Inc. and the Registrant
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2019
THIRD AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
Blueprint Medicines Corp
Biotechnology
2016